Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Seres Therapeutics (MCRB) Debt Ratio: 2015-2024

Historic Debt Ratio for Seres Therapeutics (MCRB) over the last 4 years, with Jun 2024 value amounting to 0.32.

  • Seres Therapeutics' Debt Ratio rose 28.51% to 0.32 in Q2 2024 from the same period last year, while for Jun 2024 it was 0.32, marking a year-over-year increase of 28.51%. This contributed to the annual value of 0.28 for FY2023, which is 95.22% up from last year.
  • According to the latest figures from Q2 2024, Seres Therapeutics' Debt Ratio is 0.32, which was up 6.57% from 0.30 recorded in Q1 2024.
  • Over the past 5 years, Seres Therapeutics' Debt Ratio peaked at 0.32 during Q2 2024, and registered a low of 0.04 during Q3 2021.
  • In the last 3 years, Seres Therapeutics' Debt Ratio had a median value of 0.22 in 2023 and averaged 0.23.
  • As far as peak fluctuations go, Seres Therapeutics' Debt Ratio crashed by 71.41% in 2021, and later surged by 300.97% in 2022.
  • Over the past 5 years, Seres Therapeutics' Debt Ratio (Quarterly) stood at 0.07 in 2020, then declined by 3.34% to 0.07 in 2021, then surged by 108.87% to 0.15 in 2022, then surged by 95.22% to 0.28 in 2023, then climbed by 28.51% to 0.32 in 2024.
  • Its Debt Ratio was 0.32 in Q2 2024, compared to 0.30 in Q1 2024 and 0.28 in Q4 2023.